Health Condition 1: H259- Unspecified age-related cataract
Conditions
Interventions
Intervention1: Single arm: Siddha Collyrium Neelanjana mai
Dose 1mg Apply with the ring finger in the inner canthus of affected eyes morning after sunrise and evening before sunset for the duration of
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both the sex who met the diagnostic standards of senile cataract Patients dignosed with cataracts on slitlamp microscopy of any type of cataract within the grade of less than Grade 2 or equal to grade 2
Exclusion criteria
Exclusion criteria: Patients suffering from congenital cataracts hypemature cataracts glaucoma diabetic retinopathy macular degenration and retinitis pigmentosa Patients whose random blood sugar levels and blood pressure are not within normal limits Patients who are under steroid treatment and or any kind of immunosuppressive theraphy or under any cataract inducing medication will be excluded Patients with a grading of more than Grade2 under Slit Lamp mictoscope will exclude the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Neelanjana mai for the management of vellai patalam by measuring Slit lamp examination in the 90 days of clinical observation including follow upTimepoint: To evaluate the efficacy of Neelanjana mai for the management of vellai patalam by measuring Slit lamp examination in the 90 days of clinical observation including follow up | — |
Secondary
| Measure | Time frame |
|---|---|
| To asses the safety of Neelanjana maiTimepoint: 0 15 30 45 and follow up 90 | — |
Countries
India
Contacts
Public ContactDr R Thilagavathi
Siddha Clinical Research Unit
Outcome results
None listed